Deletion or mutations of the tumor suppressor p53 in murine models of triple-negative breast cancer have recently been reported to enhance neutrophilic inflammation, which is mediated by tumor cell production of WNT ligands promoting the secretion of IL-1β by TAMs (55, 56). The gene discussed is TP53; the disease is neoplasm.